The world’s first needle-free continuous glucose monitor to prevent and manage d...
The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale
Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it.
Proper management of diabetes starts with consistent and accura...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PDC2021-121470-C21
PREDICCION DE GLUCOSA SIN INTERVENCION DEL USUARIO PARA EL A...
69K€
Cerrado
Lassie
Lassie: The first-ever painless breath analyser for people w...
11M€
Cerrado
PDC2021-121470-C22
HERRAMIENTA DE APRENDIZAJE AUTOMATICO QUE MINIMIZA EL RIESGO...
69K€
Cerrado
CPP2021-008659
Hacia una nueva generación de soluciones digitales para la d...
275K€
Cerrado
DPI2010-20764-C02-02
NUEVAS ESTRATEGIAS DE CONTROL GLUCEMICO POSTPRANDIAL MEDIANT...
224K€
Cerrado
MAGIC
Minimally invasive reliAble Glucose monitoring in Intensive...
5M€
Cerrado
Información proyecto PREVENTDIABETES
Duración del proyecto: 19 meses
Fecha Inicio: 2022-06-17
Fecha Fin: 2024-01-31
Líder del proyecto
GLUCOMODICUM OY
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
7M€
Descripción del proyecto
Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it.
Proper management of diabetes starts with consistent and accurate monitoring of glucose levels. Yet, most diagnosed diabetics do not monitor their blood sugar as often as prescribed, because it is painful and inconvenient to do so. This is clear evidence that the €16+ billion glucose monitors industry needs a change – the current methods are not good enough.
We have invented, patented and productized a new technology category for extracting and analysing blood sugar levels in a completely non-invasive way. We are applying for the EIC blended finance to further miniaturise, optimise, and clinically prove this technology on a wider scale. The financing will turn our break-through scientific discovery into an end user device that can potentially impact over 2 billion people by helping them prevent diabetes onset altogether.